News | Molecular Imaging | July 08, 2015

Large neuroimaging study finds nuclear imaging method can distinguish TBI from post-traumatic stress disorder

SPECT, traumatic brain injury, TBI, post-traumatic stress disorder, PTSD

July 8, 2015 - After comparing more than 20,000 brain scans, researchers have identified differences between traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) despite both conditions sharing common symptoms.

"This discovery is breakthrough information for anyone diagnosed with either TBI or PTSD or both," said Theodore Henderson, M.D., Ph.D., a co-author of the study, published in PLOS One. "Now that we can tell the difference between TBI and PTSD, clinicians can apply more targeted and appropriate treatments, and achieve advances with their patients."

Believed to be the largest functional neuroimaging study ("Functional Neuroimaging Distinguishes Post traumatic Stress Disorder from Traumatic Brain Injury in Focused and Large Community Datasets"), researchers used single photon emission computed tomography (SPECT) to obtain biological differences between TBI and PTSD in the brain. This neuroimaging method and landmark study "demystify" these two conditions that both may appear with symptoms like anxiety, depression, mood dysregulation, irritability and other cognitive breakdowns, according to Henderson.

"This study contained a subset of closely matched patients and a larger dataset of "˜real world' patients with multiple psychiatric or neurological conditions. The accuracy of the closely matched study was 100 percent, which replicates our research on veterans with TBI or PTSD (wherein the accuracy was 94 percent). It clearly delineates the potential of SPECT as a biomarker in differentiating TBI from PTSD - a critical issue for anyone suffering from symptoms with no answers," said Henderson, a Denver-based psychiatrist specializing in treating complex conditions.

Henderson emphasized the importance of obtaining an accurate diagnoses for TBI or PTSD. "They may have similar symptoms, but treatments are very different," he said.

"For example, some treatments for PTSD can actually be useless and possibly even harmful for TBI," said Henderson. "Plus, TBI can refer to injury to any part of the brain, which would require different treatments as well."

Henderson said this news will be particularly noteworthy for the millions of Americans who have played contact sports, citing sport-related concussion incidence rates being reported to top 3 million per year, according to the Center for Disease Control. "I hope to reach out to all the active and retired football players and athletes suffering from either of these conditions."

For more information: www.plosone.org


Related Content

News | ARRS

Feb. 11, 2026 —The American Roentgen Ray Society (ARRS) has announced the following radiologists, as well as their ...

Time February 13, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 6, 2026 — A state-of-the-art intraoperative MRI (iMRI) has arrived at the University of Chicago Medicine, one of ...

Time February 06, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 27, 2026 — Hyperfine has announced results from the largest data set to date evaluating stroke detection with its ...

Time January 28, 2026
arrow
News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...

Time January 20, 2026
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | PET Imaging

Oct. 22, 2025 — Vistim Labs has announced that its flagship product, Ceregram, is officially ready for launch in ...

Time October 22, 2025
arrow
News | Focused Ultrasound Therapy

Aug. 26, 2025 — In a quest for ever-more-effective treatments for pancreatic cancer, HonorHealth Research Institute is ...

Time August 29, 2025
arrow
News | Nuclear Imaging

May 5, 2025 — GE HealthCare recently announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance ...

Time May 06, 2025
arrow
Subscribe Now